Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Immune thrombocytopenic purpura and myocardial infarction: a dilemma of management.

Zaid G, Dawod S, Rosenschein U.

Isr Med Assoc J. 2013 Dec;15(12):775-6. No abstract available.

2.

Tailored antiplatelet therapy in a patient with ITP and clopidogrel resistance.

Mendolicchio GL, Zavalloni D, Bacci M, Roveda M, Quagliuolo V, Anselmi CV, Rota LL, Ruggeri ZM.

Thromb Haemost. 2015 Mar;113(3):664-7. doi: 10.1160/TH14-09-0751. Epub 2014 Nov 27. No abstract available.

PMID:
25428265
3.
4.

Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature.

Neskovic AN, Stankovic I, Milicevic P, Aleksic A, Vlahovic-Stipac A, Calija B, Putnikovic B.

Herz. 2010 Jan;35(1):43-9. doi: 10.1007/s00059-010-3262-1. Epub 2010 Feb 9. Review.

PMID:
20140789
5.

Refractory autoimmune thrombocytopenia: response to antiplatelet therapy.

Nachman RL.

Lancet. 2005 Oct 15-21;366(9494):1410. No abstract available.

PMID:
16226620
7.

Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.

Lin GM, Li YH.

Am J Cardiol. 2011 Feb 15;107(4):641. doi: 10.1016/j.amjcard.2010.11.001. No abstract available.

PMID:
21295179
8.

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Ernst NM, Suryapranata H, Miedema K, Slingerland RJ, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Zijlstra F, van 't Hof AW.

J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93.

9.

Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura.

Lotta LA, Mancini I, Tuana G, Musallam KM, Peyvandi F.

J Thromb Thrombolysis. 2012 Oct;34(3):416-8.

PMID:
22450533
10.

Clopidogrel-associated autoimmune thrombocytopenic purpura.

Best PJ, Mathew V, Markovic SN.

Catheter Cardiovasc Interv. 2004 Jul;62(3):339-40.

PMID:
15224300
11.

[A case of intracoronary stent implanted for acute myocardial infarction in an elderly patient with idiopathic thrombocytopenic purpura].

Kikuchi S, Hayashi Y, Fujioka S, Kukita H, Ochi N.

Nihon Ronen Igakkai Zasshi. 2002 Jan;39(1):88-93. Japanese.

12.

Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.

Di Sciascio G, Patti G, Pasceri V, Colonna G, Mangiacapra F, Montinaro A; ARMYDA-4 RELOAD Investigators.

Eur Heart J. 2010 Jun;31(11):1337-43. doi: 10.1093/eurheartj/ehq081. Epub 2010 Apr 2.

13.

[Primary angioplasty in a patient with acute inferior myocardial infarction: the unexpected trap].

Ebert AG, Casarosa F, Colivicchi F, Limbruno U.

G Ital Cardiol (Rome). 2013 Oct;14(10):669-71. doi: 10.1714/1335.14833. Italian.

PMID:
24121891
14.

[Assessment of clinical and antiaggregation efficacy of generic clopidogrel 'Egithromb' in roentgenosurgical practice].

Loenko VB, Sorokina EA, Faĭl' IL, Smialovskiĭ DV.

Angiol Sosud Khir. 2013;19(1):19-23. Russian.

PMID:
23531655
15.

Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy.

Balbi M, Fedele M, Bezante GP, Brunelli C, Barsotti A.

J Cardiovasc Med (Hagerstown). 2011 Nov;12(11):839-42. doi: 10.2459/JCM.0b013e328337d7e7. No abstract available.

PMID:
20216229
16.

Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura.

Stouffer GA, Hirmerova J, Moll S, Rubery B, Napoli M, Ohman EM, Simpson R.

Catheter Cardiovasc Interv. 2004 Mar;61(3):364-7.

PMID:
14988897
17.

Bedside evaluation of thienopyridine antiplatelet therapy.

Price MJ.

Circulation. 2009 May 19;119(19):2625-32. doi: 10.1161/CIRCULATIONAHA.107.696732. Review. No abstract available.

18.

Beware of being caught on the rebound.

Lordkipanidzé M, Harrison P.

J Thromb Haemost. 2011 Jan;9(1):21-3. doi: 10.1111/j.1538-7836.2010.04125.x. No abstract available.

19.

Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.

McCullough PA, Marks KR.

J Thromb Thrombolysis. 1999 Jun;7(3):233-9. Review. No abstract available.

PMID:
10373716
20.

There is no place like home after successful percutaneous coronary intervention.

Gilchrist IC.

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1017-8. doi: 10.1002/ccd.22336. No abstract available.

PMID:
19953518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk